Ending the Diagnostic Odyssey Act of 2021
- Last Action
- 6/10/2021
Actions
- 2021-06-10Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4046-4047)
- 2021-06-10Introduced in Senate
CRS Summary
As of 2021-06-10 (00)
Ending the Diagnostic Odyssey Act of 2021
This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.
Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease.
The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.
Cosponsors (3)
- Mark Kelly (D-AZ)
- Robert Menendez (D-NJ)
- Tina Smith (D-MN)
Subjects
- Adoption and foster care
- Cell biology and embryology
- Child health
- Emergency medical services and trauma care
- Genetics
- Health care costs and insurance
- Health care coverage and access
- Health care quality
- Health programs administration and funding
- Health technology, devices, supplies
- Hospital care
- Medicaid
- Medical tests and diagnostic methods
- State and local government operations
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.